These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6895378)

  • 1. Generation of fibrinolytic activity by infusion of activated protein C into dogs.
    Comp PC; Esmon CT
    J Clin Invest; 1981 Nov; 68(5):1221-8. PubMed ID: 6895378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C and fibrinolysis: a link between coagulation and fibrinolysis.
    de Fouw NJ; Haverkate F; Bertina RM
    Adv Exp Med Biol; 1990; 281():235-43. PubMed ID: 2102614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
    Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
    Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species specificity of the fibrinolytic effects of activated protein C.
    Weinstein RE; Walker FJ
    Thromb Res; 1991 Jul; 63(1):123-31. PubMed ID: 1835179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.
    Colucci M; Stassen JM; Collen D
    J Clin Invest; 1984 Jul; 74(1):200-4. PubMed ID: 6547456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein C in vivo.
    Comp PC; Jacocks RM; Ferrell GL; Esmon CT
    J Clin Invest; 1982 Jul; 70(1):127-34. PubMed ID: 6177716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Korninger C; Collen D
    Thromb Haemost; 1981 Aug; 46(2):561-5. PubMed ID: 6795744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
    Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.
    Sakata Y; Curriden S; Lawrence D; Griffin JH; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1121-5. PubMed ID: 3871946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood clot lysis: in vitro modulation by activated protein C.
    Taylor FB; Lockhart MS
    Thromb Res; 1985 Mar; 37(6):639-49. PubMed ID: 3838829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
    Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
    Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
    Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.